Abstract
MicroRNAs (miRNAs) are small non-coding elements involved in the post-transcriptional down-regulation of gene expression through base pairing with messenger RNAs (mRNAs). Through this mechanism, several miRNA–mRNA pairs have been described as critical in the regulation of multiple cellular processes, including early embryonic development and pathological conditions. Many of these pairs (such as miR-15 b/BCL2 in apoptosis or BART-6/BCL6 in diffuse large B-cell lymphomas) were experimentally discovered and/or computationally predicted. Available tools for target prediction are usually based on sequence matching, thermodynamics and conservation, among other approaches. Nevertheless, the main issue on miRNA–mRNA pair prediction is the little overlapping results among different prediction methods, or even with experimentally validated pairs lists, despite the fact that all rely on similar principles. To circumvent this problem, we have developed miRGate, a database containing novel computational predicted miRNA–mRNA pairs that are calculated using well-established algorithms. In addition, it includes an updated and complete dataset of sequences for both miRNA and mRNAs 3′-Untranslated region from human (including human viruses), mouse and rat, as well as experimentally validated data from four well-known databases. The underlying methodology of miRGate has been successfully applied to independent datasets providing predictions that were convincingly validated by functional assays. miRGate is an open resource available at http://mirgate.bioinfo.cnio.es. For programmatic access, we have provided a representational state transfer web service application programming interface that allows accessing the database at http://mirgate.bioinfo.cnio.es/API/
Database URL: http://mirgate.bioinfo.cnio.es
Introduction
In the past few years, the functional role of non-coding RNAs have been associated to crucial cellular processes, such as gene regulation (1) and chromatin modification (2). This evidence has been supported by the Encyclopedia of DNA Elements project which revealed that most of our non-coding genome is actively transcribed and that a substantial percentage of the genome is active at the transcriptional level (3). Among non-coding RNAs, the microRNAs (miRNAs) family has become relevant by their important regulatory role. miRNAs are small non-coding elements of ∼22 nt involved in the post-transcriptional fine-tuning regulation of gene expression, either through messenger RNA (mRNA) degradation or by translation prevention (4, 5). Recently, other mechanisms such as elongation inhibition or ribosome drop-off (premature termination) have been described (5). miRNAs have also been associated with many other relevant functions: apoptosis, cell growth, cell proliferation and differentiation in prokaryotes and eukaryotes organisms (6, 7). Several independent studies have predicted that miRNAs regulate 20–30% of human genes, but some authors raise this estimate considerably to 92% (8, 9). Alterations of the expression patterns of multiple miRNAs have been associated to pathological conditions such as cancer (10, 11), neurodegenerative diseases (12) and heart diseases (13).
Basic miRNA mechanism of action relies on binding their seed sequence (an evolutionary-conserved region of 5–7 nt at the 5′-end of the miRNA) to a complementary sequence in the 3′-UTR of its targeted mRNA (9). Sometimes additional pairing is needed at the 3′ of the miRNA to compensate non-Watson–Crick pairs called wobbles (14). Besides the complementarity and the conservation of the pairing sequences, some other factors may influence the pairing specificity and underlying function. For example, target sites surrounding long UTR edges were associated with lower expressed protein levels than those around the centre of the sequence (15). Besides, functional targets show a high proportion of adenines and uracils next to the binding site (16). Other basic factors highly related to active targets are miRNA cooperation (17), where a plausible effect in regulation is identified when several miRNAs are simultaneously bound to the same mRNA (rather than separately), and thermodynamic stability, where favourable energy is determined among the bound and unbound RNA double strand (18).
Several algorithms offer target prediction based on the combination of these conditions. They predict targets using miRNA and 3′-UTR sequences from selected protein coding transcripts known at that moment. The distinct approaches provide scores, energy or conservation values to highlight the reliability of the prediction. As each tool employs different criteria that govern a functional target, several integrative approaches emerged to offer these already calculated predictions combined, to ensure all possible restrictions. Some examples of these valuable efforts are MiRonTop (19), mirGator (20), mirWalk (21), MAGIA2 (22) or microRNA and mRNA Integrated Analysis (23). Many of them emphasize two of the most disturbing facts in the field, which are the lack of overlap between the different target prediction methods and the poor reliability found when predictions are validated using proteomics techniques.
The development of a tool based on a complete, consistent and unique dataset could avoid such problems increasing the reliability of miRNA and gene variants target studies (24). For this reason, we have developed miRGate, which uses a common dataset—rather than download pre-compiled data—to compute all possible targets from miRNAs sequences available in miRBase, and a complete 3′-UTR sequence dataset retrieved from EnsEMBL. Additionally, it also stores information of experimentally validated targets to test the reliability of predicted targets and provides valuable information to distinguish weak predictions.
To our knowledge, miRGate is the only available tool that addresses the little overlap among different targets using a common and an updated dataset. miRGate has been designed to jointly analyse miRNA and gene or gene variants lists in human, (including human viruses, such as Epstein–Barr and Kaposi sarcoma-associated herpes virus), mouse and rat to provide a novel catalogue of accurate in house predicted miRNA targets and programmatically access to the predictions in a massive way through RESTful web services.
Methods
miRGate composed of diverse steps where data from different sources are processed and used as input for several algorithms. Results from these tools along with external information are converted and stored in a relational database. Scores from any individual prediction obtained from the different tools are processed to allow a comparison among algorithms results.
A schematic representation of all steps is shown in the Supplementary Figure S1.
Sequence space
To compute high reliable miRNA–mRNA targets, we created a consistent dataset of updated and complete sequences for miRNAs [based on miRBase 20 (25)] and 3′-UTR sequences for human, mouse and rat [based on EnsEMBL 74 (26)]. A complete summary of the 3′-UTR sequence dataset is presented in Table 1. Unlike other databases, we include in miRGate all known isoforms for all known genes stored in EnsEMBL, as each isoform can have an exclusive 3′-UTR. This contains, e.g. non-coding genes, pseudogenes [as they have been related to the regulation of the activity of cancer-related genes (27)] and mitochondrial RNAs, among others biotypes catalogued in Havana. A full comparison of sequences included in other databases/algorithms versus miRGate is presented in Supplementary Table S1. The untranslated sequences dataset used in this work are retrieved along with all provided annotations: HUGO Gene Nomenclature Committee name for human genes, gene and transcript names, genomic coordinates and Havana biotypes among others. Since not every transcript has a known UTR sequence, or some are smaller than 50 bp, 130 bp downstream from the end of the last exon were used as predicted UTR, as this size corresponds to the mode length of all known 3′-UTRs in human, mouse and rat (Figure 1). Additionally, miRGate provides protein structural information, functional and sequence conservation information for gene-oriented high throughput experiments using Annotating principal splice isoforms (28), which defines a principal variant: the gene isoform which is expressed in most of the tissues, for each gene in human, mouse and rat (29, 30).
Table 1.
Name | Build, year | Coding genes | Nc-genes | Pseudogenes | 3′-UTR |
---|---|---|---|---|---|
miRanda | NCBI37, 2009 | 19 778 | — | — | 34 592 |
TargetScan | NCBI37, 2009 | 18 414 | — | — | 30 932 |
Pita | NCBI36, 2006 | 18 582 | — | — | 24 086 |
PicTar | NCBI35, 2005 | 20 254 | — | — | 20 254 |
miRGate | NCBI37, 2009 | 20 805 | 22 966 | 14 181 | 196 501 |
For miRNA sequences, we rely on miRBase 20 (25), which is the central database for miRNA sequence annotation and nomenclature registry. MiRBase 20 contains 24 521 pre-miRNAs, expressing 30 424 mature sequences in 206 species. In miRGate, we stored human, human viruses, mouse and rat miRNA sequences (Table 2), as well as other available information such as cleavage data from pre-miRNAs to mature miRNAs, genomic coordinates and family names.
Table 2.
Name | human | mouse | rat | Database Version |
---|---|---|---|---|
miRanda | 1100 | 717 | 387 | miRBase 15 |
TargetScan | 1433 | 722 | — | miRBase 17 |
Pita | 692 | 500 | — | miRBase 11 |
PicTar | 81 | 81 | 81 | Rfam 5 |
miRGate | 2680 | 1983 | 763 | miRBase 20 |
Algorithms
One of our main motivations is to be able to determine accurate and novel targets from our own dataset. Although there are many freely available methods that provide miRNA target predictions for standard gene sequences, just a few of them allow prediction on provided sequences.
We compute miRNA target predictions using: (i) miRanda (31), which uses dynamic programming score alignments based on the complementary of nucleotides; (ii) Pita (32), which identifies full complementary seeds for each miRNA and calculates favourable energy among the bound and unbound double strand; (iii) RNAHybrid (33), that is based on favourable hybridization sites avoiding intramolecular duplexes; (iv) Microtar (34) that assess target sites based on RNA duplex energy calculation and (v) TargetScan (35), which scores predictions based on seed match, binding site localization and target conservation among the species. For Pita conservation score calculation, Phastcon hidden Markov model phylogenetic information (36) was added. In the case of TargetScan, EnsEMBL alignments for mammals were used (26). All information provided by the methods is stored, including target sites, energy scores, conservation scores, miRNA and mRNA coordinates and it is available for users. A complete description of the features included in each algorithm can be consulted in Table 3.
Table 3.
Name | Type | Score | Version | Features |
---|---|---|---|---|
miRanda | Prediction tool | Energy > 140 kcal | 3.3a | miRanda uses dynamic programming to score alignments based of the complementarity of nucleotides, allowing G-U wobble pairs. |
Pita | Prediction tool | Conservation > 0.5 | NA | Identifies initial full complementary seeds for each miRNA in the mRNA and computes the free energy of the unbound and bound double strand. It uses a phylogenetic hidden Markov model (34) called Phastcons; to filter out less conserved predicted target sites. |
RNAHybrid | Prediction tool | Score > 0 | 2.2 | Finds energetically most favourable hybridization sites avoiding intramolecular hybridization. Poisson approximation of multiple binding sites and calculation of effective numbers of orthologous targets in comparative studies of multiple organisms are assessed. |
microtar | Prediction tool | Energy < 0 Kcal | NA | A program based on mRNA sequence complementarity and RNA duplex energy prediction by using Vienna package, assessing the impact of miRNA binding on complete mRNA molecules. |
TargetScan | Prediction tool | Conservation in mammals | 6 | This algorithm requires perfect seed pairing to score the predictions according the type of the seed match, local AU contribution and mRNA binding site localization. |
Tarbase | Validated target database | — | 6 | Contains detailed information for each miRNA–gene interaction, ranging from miRNA and gene-related facts to information specific to their interaction, including the experimental validation methodologies and their outcomes. All database entries are enriched with function-related data, as well as general information derived from external databases such as UniProt, Ensembl and RefSeq. |
miRTarbase | Validated target database | — | 4.5 | It contains more than 51 000 validated miRNA-gene interactions which are collected by manually surveying pertinent literature retrieved by means of a text mining process aiming at research articles related to functional studies of miRNAs |
miRecords | Validated target database | — | — | miRecords hosts a large, high-quality manually curated database of experimentally validated miRNA-target interactions with systematic documentation of experimental support for each interaction using text mining techniques. |
OncomirDB | Validated target database | — | — | OncomirDB contains targets that have been validated and published in ∼9000 abstracts. A total number of 2259 manually curated entries with direct experimental evidences were stored. |
Experimentally validated data
To contrast the predictions with experimentally validated miRNA–mRNA targets, miRGate also compiles information obtained with several validation methodologies and extracted from four different public databases: (i) Tarbase (37) and (ii) miRTarbase (38), which relay on text mining techniques to identify validated targets; (iii) miRecords (39), that manually curates targets mentioned in those publications selected using a systematic documentation strategy and (iv) OncomirDB (40), that publishes validated miRNA–mRNA targets by manually curating 9000 abstracts. In the case of human, the validated dataset from Tarbase (37), miRTarBase (38), miRecords (39) and OncomirDB (40) comprises 79 046 targets where only 40 991 (52%) of the mRNA–miRNA pairs are unique (Figure 2). A more detailed description of the experimental databases is shown in Table 3.
Results
Standardized prediction meta-score
The list of predictions (see Table 4 for a summary) is ranked by a Z-score that was computed by standardizing individual raw scores in each prediction among all predictions collected in the database. When more than one prediction algorithms in miRGate predict a identical target for the same miRNA and 3′-UTR in equivalent genomic coordinates, the results are combined generating a consensus weighted score (CWS) as it has been previously described (41).
For each identical prediction, obtained for a different algorithm, let Zi be the standardized score produced by that tool and Wi corresponds to the probability that an above-the-score prediction is not a false positive, given the complementary cumulative distribution of scores shown by the ith tool when comparing its predictions against a dataset of validated targets.
Table 4.
human | mouse | rat | ||
---|---|---|---|---|
miRanda | 34 838 559 | 16 164 311 | 1 372 897 | |
Pita | 773 112 | 313 113 | 52 281 | |
RNAHybrid | 36 832 689 | 10 390 354 | 536 248 | |
microtar | 6 049 837 | 1 750 058 | 3 348 100 | |
Targetscan | 7 270 936 | 5 186 036 | 417 501 | |
TarBase | 36 853 | 20 513 | 7 | |
miRTarbase | 39 118 | 9 314 | 307 | |
miRecords | 1 198 | 227 | — | |
OncomirDB | 2 368 | 1 917 | — | |
miRGate | 85 844 670 | 33 835 843 | 5 727 341 | 125 407 854 |
This approach was found to improve the reliability of predictions from different methods that although different in nature, reflects in this particular case, the probability of a miRNA to bind to a complementary sequence of an mRNA region.
Validation
Although miRGate uses established and well-known prediction algorithms, we evaluated the predictions obtained by those methods against a dataset of experimentally validated targets. Z-scores and consensus-weighted scores were plotted using ROC (receiver operating characteristic) (42). The integrative approach designed in miRGate outperforms the result of each method separately (Figure 3). Outperformance increases more drastically when miRGate predictions are then compared against available pre-compiled targets, obtaining an average increment of 10%. The true-positive rate is even better, when the false positive rate is over 0.6. (Figure 4).
We also observed that better accuracy is obtained when target prediction results are contrasted with the more confident targets. In that sense, datasets were divided according to a reliability criteria: (i) OncomirDB (40) as a manually curated database (highly reliable), (ii) miRecords (39) as a partially curated dataset (medium reliability) and (iii) a combined dataset comprised two text mining prediction sources, mirTarbase (38) and Tarbase (37), as low reliability. The area under the curve (AUC) rises from 0.6, in low reliable, to 0.78 in high confident targets (Figure 5).
In summary, the incorporation of this complete dataset in miRGate has improved the prediction reach of the individual methods (a 10–21% improvement in performance), as seen by the comparison of the whole set versus individual methods when using experimental confirmed datasets. This improvement is even notorious when we compared the data in our database against the pre-compiled datasets that other integrative methods employ.
Moreover, miRGate has been successfully applied to independent datasets providing predictions that were validated using different experimental techniques from diverse transcriptome profiling technologies (such as microarrays, RNA-Seq or miRNA-Seq). To date, eight different works have successfully validated miRGate targets using different experimental procedures (43–50).
Web interface
miRGate database can be accessed through a web page to search for potential targets to their genes and/or miRNAs of interest.
The page is designed as an intuitive step-by-step form where users fill basic information such as organism and gene/miRNA names using gene symbols, miRNAs names, miRNAs accessions, EnsEMBL genes, EnsEMBL transcript Identificators or even probe names from different expression array platforms. To unify entity nomenclature and make easier the data introduction, the web page includes a type-ahead function that allows selecting miRNAs or genes names included in miRGate, similar to the provided input. As an optional step, miRGate provides an advanced feature where several filtering options can be adjusted. Among them, we highlight the possibility to filter by ENCODE principal isoforms (29), HAVANA biotypes and/or predicted 3′-UTR mRNA sequences. We also provide a novel feature, not present in other methods, that considers an overlap when the binding event between the miRNA seed and the mRNA 3′-UTR occurs in the same genomic position. Hence, it is possible to label remarkably agreed predictions when two or more different algorithms coincide predicting the same target in terms of target site type and RNA coordinates.
It is worth mentioning that those predictions that have been found to be experimentally corroborated (i.e. contained in at least one of the four experimental databases incorporated in miRGate) are highlighted in bold in the web page to make their identification easier to the user. Besides, for each 3′-UTR, we provide links to APADB (51), a database for alternate polyadenylation that provides information of potential loss of miRNA binding sites.
All results can be saved in csv format for downstream analyses. Details regarding the number of miRNAs and 3′-UTRs in comparison with other integrative analysis are provided in Supplementary Table S1.
RESTful API
Representational state transfer (REST) is often used as an alternative to Simple Object Access Protocol to deploy web services (52). miRGate provides a EXtensible Markup Language-based REST application programming interface (API) to allow automated queries in the database using remote programmatic tools. Using this interface, the server can be accessed from multiple programming languages, allowing researchers to wire miRGate results to their analysis pipelines. The current API version allows gene/miRNAs retrieval operations (as cleavage information, gene localization or seed sequence recovering for miRNAs or isoform localization, ENCODE annotation or Havana biotype for genes), including data sources listing, catalogue listing and query execution to retrieve detailed information about predicted and validated targets sites.
Details and examples of the implementation of the RESTful miRGate API in the Perl language are provided in the online documentation (http://mirgate.bioinfo.cnio.es/API/api.html).
Discussion
The aim of miRGate is to provide a reliable miRNA–mRNA pairs database and at the same time to fill the gap among predicted and non-concordant experimentally validated targets. At present, existing alternatives rely on pre-compiled targets from external resources. As an example, mirGator (20) uses a human dataset with pre-compiled targets from Pita (32), PicTar (53), TargetScan (35) and miRanda (31), which implies three different human builds and hence a different and a dissonant number of 3′-UTR sequences. mirWalk (21) calculates possible targets using RNAHybrid (33) software, but as other databases, it combines the results with previous computed targets from different sources and consequently discordant datasets. Since a considerably increase of overlap is obtained among target predictions or validated pairs lists when prediction methods are run using a common source of annotation (24), we designed miRGate database to use a complete dataset built on up-to-date sources that provide full miRNA and 3′-UTR sequences. Our dataset was used as a common input for five different public algorithms that predict miRNA–mRNA targets and integrated in a relational database. To our knowledge, miRGate is the only available tool that reconciles the existing disagreement among predicted pairs and experimental validated pairs. The methodology implemented in miRGate, resulted in an increase of 10–21% in accuracy when our predictions are compared to pre-compiled datasets employed by other tools versus a dataset of validated miRNA–mRNA targets.
It is also important to note that miRGate database, unlike other tools, includes all variants of every gene in human, mouse and rat that potentially could be expressed in any experimental condition (including pseudogenes, antisense transcripts, non-coding genes among others). Others focus on protein coding isoforms or the longest protein-coding variant, underrating the number of regulatory elements of the gene. A complete 3′-UTR dataset is essential as these regions contain several regulation motifs that control the expression and harbour miRNA binding sites and/or other regulatory sequences. Longer 3′-UTRs will more likely possess such signals, or more of them, and the mRNA will likely be more subjected to regulation (54). Furthermore, the length of the 3′-UTR can affect not only the stability but also the localization, transport and translational properties of the mRNA (55). Other important reason that supports a complete dataset inclusion is based on the restriction rules that dictate an effective target site; for instance, binding positions over the 3′-UTR, AU enrichment and miRNA binding cooperation along the 3′-UTR sequence. As these features are sequence dependent and a gene may have several and different 3′-untranslated sequences, the real regulation by miRNAs should be determined taking into account all 3′-regulatory sequences. Poliseno et al. (26) confirmed this observation, where a pseudogene was found to be responsible of a miss-regulation of PTEN1. For this reason, the inclusion in miRGate of all variants allows us to provide a complete and undistorted regulation network that potentially controls cellular processes where gene isoforms are expressed.
miRGate includes miRNAs virus–host target gene pair’s prediction such as Epstein–Barr and Kaposi sarcoma-associated herpesvirus. Little information is found about these viruses as most of other databases focus on intra-organism target predictions, but miRGate calculated pairs were successfully validated in diffuse large B-cell lymphomas (42) and Burkitt lymphoma samples infected with Epstein–Barr virus miRNAs (43). Apart from viruses, miRGate has also been used in hereditary breast tumour samples, hyperdiploid multiple myelomas, mantel cell lymphomas and B-cell lymphomas where expression levels of isoforms and/or miRNAs were measured using distinct techniques. In all cases, miRGate provided targets that were confirmed, pointing the suitability of this tool to the scientific community (43–50).
In addition, miRGate can be accessed as a RESTful API, enabling the integration and inter-operation of diverse sources based on related technology. miRGate API is designed to provide all stored information and it can be implemented with other catalogued services in analyses pipelines. We believe that this could be a very helpful tool as it offers a fast, automatic, customizable and integrated query execution.
To summarize, miRGate is a unique catalogue of reliable in-house-predicted miRNA targets and also experimentally validated pairs for the scientific community that is publicly available, either as a web page or as a RESTful web service. It includes a common, complete and updated dataset from miRNAs and all known gene variants for human, mouse and rat providing high confident predictions. Of note, miRGate succeed to provide useful targets obtained from different transcriptomic techniques that were robustly validated.
Supplementary Data
Supplementary data are available at Database Online.
Acknowledgements
The authors thank Rocio Nuñez, Ana M. Rojas Mendoza, Alfonso Valencia and Elena López for critical reading of the manuscript. They thank Rocio Nuñez for her helpful comments on the web page usability.
Conflict of interest. None declared.
References
- 1.He L., Hannon G.J. (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet., 5, 522–531. [DOI] [PubMed] [Google Scholar]
- 2.Yoo A.S., Staahl B.T., Chen L., et al. (2009) MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature, 460, 642–646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Consortium E.P., Bernstein B.E., Birney E., et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Shukla G.C., Singh J., Barik S. (2011) MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol., 3, 83–92. [PMC free article] [PubMed] [Google Scholar]
- 5.Morozova N., Zinovyev A., Nonne N., et al. (2012) Kinetic signatures of microRNA modes of action. RNA, 18, 1635–1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lee C.T., Risom T., Strauss W.M. (2007) Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. DNA Cell Biol., 26, 209–218. [DOI] [PubMed] [Google Scholar]
- 7.Shabalina S.A., Koonin E.V. (2008) Origins and evolution of eukaryotic RNA interference. Trends Ecol. Evol., 23, 578–587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lim L.P., Lau N.C., Garrett-Engele P., et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769–773. [DOI] [PubMed] [Google Scholar]
- 9.Lewis B.P., Burge C.B., Bartel D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15–20. [DOI] [PubMed] [Google Scholar]
- 10.Calin G.A., Sevignani C., Dumitru C.D., et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA, 101, 2999–3004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Costa F.F. (2010) Epigenomics in cancer management. Cancer Manag. Res., 2, 255–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Nielsen J.A., Lau P., Maric D., et al. (2009) Integrating microRNA and mRNA expression profiles of neuronal progenitors to identify regulatory networks underlying the onset of cortical neurogenesis. BMC Neurosci., 10, 98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Thum T., Galuppo P., Wolf C., et al. (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation, 116, 258–267. [DOI] [PubMed] [Google Scholar]
- 14.Bartel D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gaidatzis D., van Nimwegen E., Hausser J., et al. (2007) Inference of miRNA targets using evolutionary conservation and pathway analysis. BMC Bioinformatics, 8, 69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Grimson A., Farh K.K., Johnston W.K., et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell, 27, 91–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Farh K.K., Grimson A., Jan C., et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science, 310, 1817–1821. [DOI] [PubMed] [Google Scholar]
- 18.Min H., Yoon S. (2010) Got target? Computational methods for microRNA target prediction and their extension. Exp. Mol. Med., 42, 233–244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Le Brigand K., Robbe-Sermesant K., Mari B., et al. (2010) MiRonTop: mining microRNAs targets across large scale gene expression studies. Bioinformatics, 26, 3131–3132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Cho S., Jang I., Jun Y., et al. (2013) MiRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting. Nucleic Acids Res., 41, D252–D257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Dweep H., Sticht C., Pandey P., et al. (2011) miRWalk—database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J. Biomed. Inform., 44, 839–847. [DOI] [PubMed] [Google Scholar]
- 22.Bisognin A., Sales G., Coppe A., et al. (2012) MAGIA(2): from miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update). Nucleic Acids Res., 40, W13–W21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nam S., Li M., Choi K., et al. (2009) MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Res., 37, W356–W362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ritchie W., Flamant S., Rasko J.E. (2009) Predicting microRNA targets and functions: traps for the unwary. Nat. Methods, 6, 397–398. [DOI] [PubMed] [Google Scholar]
- 25.Kozomara A., Griffiths-Jones S. (2014) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res., 42, D68–D73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Flicek P., Amode M.R., Barrell D., et al. (2014) Ensembl 2014. Nucleic Acids Res., 42, D749–D755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Poliseno L., Salmena L., Zhang J., et al. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 465, 1033–1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Rodriguez J.M., Maietta P., Ezkurdia I., et al. (2013) APPRIS: annotation of principal and alternative splice isoforms. Nucleic Acids Res., 41, D110–D117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Harrow J., Frankish A., Gonzalez J.M., et al. (2012) GENCODE: the reference human genome annotation for the ENCODE project. Genome Res., 22, 1760–1774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Pei B., Sisu C., Frankish A., et al. (2012) The GENCODE pseudogene resource. Genome Biol., 13, R51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Betel D., Koppal A., Agius P., et al. (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol., 11, R90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kertesz M., Iovino N., Unnerstall U., et al. (2007) The role of site accessibility in microRNA target recognition. Nat. Genet., 39, 1278–1284. [DOI] [PubMed] [Google Scholar]
- 33.Kruger J., Rehmsmeier M. (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res., 34, W451–W454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Thadani R., Tammi M.T. (2006) MicroTar: predicting microRNA targets from RNA duplexes. BMC Bioinformatics, 7(Suppl 5), S20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Friedman R.C., Farh K.K., Burge C.B., et al. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 19, 92–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Siepel A., Bejerano G., Pedersen J.S., et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res., 15, 1034–1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Vergoulis T., Vlachos I.S., Alexiou P., et al. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res., 40, D222–D229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hsu S.D., Tseng Y.T., Shrestha S., et al. (2014) miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res., 42, D78–D85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Xiao F., Zuo Z., Cai G., et al. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res., 37, D105–D110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Wang D., Gu J., Wang T., et al. (2014) OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs. Bioinformatics., 30, 2237–2238. [DOI] [PubMed] [Google Scholar]
- 41.Gonzalez-Perez A., Lopez-Bigas N. (2011) Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J. Hum. Genet, 88, 440–449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Sing T., Sander O., Beerenwinkel N., et al. (2005) ROCR: visualizing classifier performance in R. Bioinformatics, 21, 3940–3941. [DOI] [PubMed] [Google Scholar]
- 43.Tanic M., Zajac M., Gomez-Lopez G., et al. (2012) Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFkappaB pathway. Breast Cancer Res. Treat, 134, 41–51. [DOI] [PubMed] [Google Scholar]
- 44.Martin-Perez D., Vargiu P., Montes-Moreno S., et al. (2012) Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma. Leukemia, 26, 180–183. [DOI] [PubMed] [Google Scholar]
- 45.Tanic M., Andres E., Rodriguez-Pinilla S.M., et al. (2013) MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours. Br. J. Cancer, 109, 2724–2734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bueno M.J., Gomez de Cedron M., Gomez-Lopez G., et al. (2011) Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway. Blood, 117, 6255–6266. [DOI] [PubMed] [Google Scholar]
- 47.Rio-Machin A., Ferreira B.I., Henry T., et al. (2013) Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype. Leukemia, 27, 925–931. [DOI] [PubMed] [Google Scholar]
- 48.Di Lisio L., Gomez-Lopez G., Sanchez-Beato M., et al. (2010) Mantle cell lymphoma: transcriptional regulation by microRNAs. Leukemia, 24, 1335–1342. [DOI] [PubMed] [Google Scholar]
- 49.Di Lisio L., Sanchez-Beato M., Gomez-Lopez G., et al. (2012) MicroRNA signatures in B-cell lymphomas. Blood Cancer J., 2, e57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Ambrosio M.R., Navari M., Di Lisio L., et al. (2014) The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infect. Agent. Cancer, 9, 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Muller S., Rycak L., Afonso-Grunz F., et al. (2014) APADB: a database for alternative polyadenylation and microRNA regulation events. Database, 2014, 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Fielding R.T., Taylor R.N. (2000) Principled design of the modern web architecture. Proceedings of the 22nd International Conference on Software Engineering. ACM, Limerick, Ireland: pp. 407–416. [Google Scholar]
- 53.Krek A., Grun D., Poy M.N., et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495–500. [DOI] [PubMed] [Google Scholar]
- 54.Sandberg R., Neilson J.R., Sarma A., et al. (2008) Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science, 320, 1643–1647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Barrett L.W., Fletcher S., Wilton S.D. (2012) Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cell. Mol. Life Sci., 69, 3613–3634. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.